Skip Nav Destination
Abstract CT106: Anti-LAG-3 antibody MK-4280 in combination with pembrolizumab for the treatment of hematologic malignancies: A Phase I/II study
Cancer Res (2019) 79 (13_Supplement): CT106.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Letong Cai
- Yuchen Li
- Jiaxiong Tan
- Ling Xu
- Yangqiu Li
Journal of Hematology & Oncology (2023) 16 (1)
- L. Chocarro
- E. Blanco
- H. Arasanz
- L. Fernández-Rubio
- A. Bocanegra
- M. Echaide
- M. Garnica
- P. Ramos
- G. Fernández-Hinojal
- R. Vera
- G. Kochan
- D. Escors
Immuno-Oncology and Technology (2022) 14: 100079.
- Luisa Chocarro
- Ana Bocanegra
- Ester Blanco
- Leticia Fernández-Rubio
- Hugo Arasanz
- Miriam Echaide
- Maider Garnica
- Pablo Ramos
- Sergio Piñeiro-Hermida
- Ruth Vera
- David Escors
- Grazyna Kochan
Cells (2022) 11 (15): 2351.
- Vibha Jawa
- Frances Terry
- Jochem Gokemeijer
- Shibani Mitra-Kaushik
- Brian J. Roberts
- Sophie Tourdot
- Anne S. De Groot
Frontiers in Immunology (2020) 11
